Sitka Biopharma Company
.jpg)
Transforming chemotherapies to further benefit patients by enhancing efficacy and improving tolerability.
Total Funding:
$5 500 000
Headquarters:
Vancouver, British Columbia, Canada
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Industry:
Women Cancer Treatment